Table 11.6b

Immunosuppression Used for Maintenance Prior to Discharge, 1993 to 2002

Recipients with Heart Transplants

		Year of Transplant
		1993	1994	1995	1996	1997	1998	1999	2000	2001	2002
Functioning Graft at Discharge		2,068	2,156	2,160	2,131	2,074	2,125	1,934	1,986	2,014	1,993
With Immunosuppression Info		2,066	2,152	2,110	1,850	2,055	2,114	1,923	1,978	1,985	1,953
Corticosteroids	Category Usage	96.5%	96.2%	94.9%	96.3%	95.7%	96.0%	95.4%	94.3%	97.1%	96.8%
	Steroids	96.5%	96.2%	94.9%	96.3%	95.7%	96.0%	95.4%	94.3%	97.1%	96.8%
Cyclosporine	Category Usage	97.5%	94.8%	86.7%	81.8%	87.7%	85.7%	82.4%	80.2%	70.3%	60.5%
	Cyclosporin	97.1%	90.1%	71.5%	3.0%	0.0%	0.0%	0.1%	0.1%	0.1%	0.0%
	Sandimmmune	0.8%	4.7%	11.3%	22.5%	18.2%	16.7%	11.2%	8.1%	4.3%	2.5%
	Neoral	0.0%	0.5%	6.1%	59.5%	71.1%	72.3%	73.3%	72.3%	58.3%	45.6%
	Gengraf	0.0%	0.0%	0.0%	0.1%	0.0%	0.0%	0.0%	1.5%	8.5%	12.8%
	Eon	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.2%	0.3%
Tacrolimus	Category Usage	0.6%	1.6%	4.3%	7.2%	9.9%	11.6%	14.1%	16.0%	30.1%	39.0%
	FK506	0.6%	1.6%	4.3%	7.2%	9.9%	11.6%	14.1%	16.0%	30.1%	39.0%
Antimetabolites	Category Usage	96.1%	95.1%	90.7%	91.1%	91.0%	91.8%	82.2%	87.7%	90.7%	83.8%
	Azathioprine	95.5%	93.6%	87.3%	79.0%	63.7%	49.9%	31.6%	19.4%	15.1%	12.4%
	Mycophenolate mofetil	0.6%	4.4%	5.8%	14.1%	31.5%	48.9%	53.9%	69.9%	78.7%	75.0%
Other	Category Usage	0.8%	0.7%	1.3%	1.3%	1.5%	1.1%	1.5%	3.4%	4.8%	10.0%
	Rapamycin	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.9%	2.6%	4.3%	9.8%
	Cytoxan	0.8%	0.7%	1.3%	1.3%	1.5%	1.0%	0.5%	0.9%	0.5%	0.2%

Source: OPTN/SRTR Data as of August 1, 2003.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.